DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,487 filers reported holding DANAHER CORPORATION in Q1 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,624,000 | +17.2% | 13,504 | -1.7% | 2.42% | +9.2% |
| Q1 2021 | $3,092,000 | -1.7% | 13,739 | -2.9% | 2.21% | -3.3% |
| Q4 2020 | $3,144,000 | -2.8% | 14,155 | -5.8% | 2.29% | -13.5% |
| Q3 2020 | $3,234,000 | +17.6% | 15,020 | -3.5% | 2.65% | +7.2% |
| Q2 2020 | $2,751,000 | +24.5% | 15,560 | -2.5% | 2.47% | +11.1% |
| Q1 2020 | $2,209,000 | -10.6% | 15,960 | -0.8% | 2.22% | +18.0% |
| Q4 2019 | $2,470,000 | +5.2% | 16,091 | -1.1% | 1.88% | +1.7% |
| Q3 2019 | $2,349,000 | -0.3% | 16,266 | -1.3% | 1.85% | -0.4% |
| Q2 2019 | $2,356,000 | +5.8% | 16,486 | -2.2% | 1.86% | +4.6% |
| Q1 2019 | $2,226,000 | +23.6% | 16,861 | -3.4% | 1.78% | +8.6% |
| Q4 2018 | $1,801,000 | -5.8% | 17,461 | -0.7% | 1.64% | +7.2% |
| Q3 2018 | $1,911,000 | +10.1% | 17,586 | 0.0% | 1.53% | +1.9% |
| Q2 2018 | $1,735,000 | +4.6% | 17,586 | +3.8% | 1.50% | +3.4% |
| Q1 2018 | $1,658,000 | +10.3% | 16,936 | +4.6% | 1.45% | +17.1% |
| Q4 2017 | $1,503,000 | – | 16,194 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |